Literature DB >> 7326610

Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls.

R Broughton, Q Ghanem, Y Hishikawa, Y Sugita, S Nevsimalova, B Roth.   

Abstract

A questionnaire survey has been made of the life effects of narcolepsy in 180 patients, 60 each from North American, Asian and European populations, with 180 similarly distributed age and sex matched controls. Life-effects were attributed by the patients to the primary symptoms of excessive daytime drowsiness, sleep attacks, cataplexy, vivid hypnagogic hallucinations and sleep paralysis, and also to other frequent symptoms such as visual problems (blurring, diplopia) and memory impairment. Occupational problems were prevalent (over 75%) and included statistically significant deleterious effects upon performance, promotion, earning capacity, fear of or actual job loss and increased disability insurance. Driving was greatly affected and patients fell asleep at the wheel more frequently (66%), had near or actual accidents from drowsiness or falling asleep at the wheel (67%), and could experience cataplexy (29%) or sleep paralysis (12%) while driving. Work or home accidents attributed to sleepiness or sleep (49%) or related to smoking (49%) were much more common in patients. There were also deleterious effects on education, recreation and personality related to disease. Narcolepsy can produce a variety of life-effects probably more serious and pervasive than, for instance, those of epilepsy, therefore emphasizing the importance of early diagnosis and treatment.

Entities:  

Mesh:

Year:  1981        PMID: 7326610     DOI: 10.1017/s0317167100043419

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  21 in total

Review 1.  Hepatic encephalopathy and sleepiness: an interesting connection?

Authors:  Sara Montagnese; Matteo Turco; Piero Amodio
Journal:  J Clin Exp Hepatol       Date:  2014-06-29

2.  Quality measures for the care of patients with narcolepsy.

Authors:  Lois E Krahn; Shelley Hershner; Lauren D Loeding; Kiran P Maski; Daniel I Rifkin; Bernardo Selim; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

3.  Assessing readiness to drive in adolescents with narcolepsy: what are providers doing?

Authors:  David G Ingram; Ann Marie Marciarille; Zarmina Ehsan; Gayln V Perry; Teresa Schneider; Baha Al-Shawwa
Journal:  Sleep Breath       Date:  2019-02-08       Impact factor: 2.816

4.  Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.

Authors:  Sandor Kantor; Takatoshi Mochizuki; Stefan N Lops; Brian Ko; Elizabeth Clain; Erika Clark; Mihoko Yamamoto; Thomas E Scammell
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

Review 5.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

Review 6.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Factors associated with duration before receiving definitive diagnosis of narcolepsy among Japanese patients affected with the disorder.

Authors:  Yoichiro Ueki; Kenichi Hayashida; Yoko Komada; Masaki Nakamura; Mina Kobayashi; Makio Iimori; Yuichi Inoue
Journal:  Int J Behav Med       Date:  2014-12

8.  Treatment of disorders of hypersomnolence.

Authors:  Olufemi Adenuga; Hrayr Attarian
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

9.  Effect of modafinil on cerebral blood flow in narcolepsy patients.

Authors:  Eun Yeon Joo; Dae Won Seo; Woo Suk Tae; Seung Bong Hong
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

10.  Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time.

Authors:  Akiko Ozaki; Yuichi Inoue; Toru Nakajima; Kenichi Hayashida; Makoto Honda; Yoko Komada; Kiyohisa Takahashi
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.